An enigmatic disease: Childhood Langerhans cell histiocytosis in 2005

International Journal of Dermatology

Volumn 45, Issue 3, 2006, Pages 182-188

  Savaşan, Süreyya ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOSIDE; PREDNISONE; VINBLASTINE;

BONE DISEASE; CHILDHOOD DISEASE; DISEASE COURSE; HISTIOCYTOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPETENCE; LANGERHANS CELL; MOLECULAR CLONING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATHOPHYSIOLOGY; RECURRENT DISEASE; REVIEW; TREATMENT FAILURE;

CHILD; DISEASE PROGRESSION; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IMMUNITY, NATURAL; RECURRENCE;

EID: 33644775656     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2006.02876.x     Document Type: Review

References (44)

1. Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Writing Group of the Histiocyte Society. Lancet 1987; 1: 208-209.
2. Favara BE, Feller AC, Pauli M, et al. Contemporary classification of histiocytic disorders. The WHO Committee on Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol 1997; 29: 157-166.
3. Weitzman S, Jaffe R. Uncommon histiocytic disorders: The non-Langerhans cell histiocytoses. Pediatr Blood Cancer 2005; 45: 256-264.
4. Chu AC. The confusing state of the histiocytoses. Br J Dermatol 2000; 143: 475-476.
5. Savasan S, Smith L, Scheer C, et al. Successful bone marrow transplantation for xanthogranuloma disseminatum in neurofibromatosis type 1. Pediatr Transpl 2005; 9: 534-536.
6. Arico M, Danesino C, Pende D, et al. Pathogenesis of haemophagocytic lymphohistiocytosis. Br J Haematol 2001; 114: 761-769.
7. Henter JI. Biology and treatment of familial hemophagocytic lymphohistiocytosis: Importance of perforin in lymphocyte-mediated cytotoxicity and triggering of apoptosis. Med Pediatr Oncol 2002; 38: 305-309.
8. Parajuli P, Nishioka Y, Nishimura N, et al. Cytolysis of human dendritic cells by autologous lymphokine-activated killer cells: Participation of both T cells and NK cells in the killing. J Leuk Biol 1999; 65: 764-770.
9. Ronchese F, Hermans IF. Killing of dendritic cells: A life cut short or a purposeful death? J Exp Med 2001; 194: F23-F26.
10. Dupre L, Andolfi G, Tangye SG, et al. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells. Blood 2005; 105: 4383-4389.
11. Villanueva J, Lee S, Giannini EH, et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther 2005; 7: R30-R37.
12. Favara BE, Jaffe R, Egeler RM. Macrophage activation and hemophagocytic syndrome in Langerhans cell histiocytosis: Report of 30 cases. Pediatr Dev Pathol 2002; 5: 130-140.
13. Grom AA. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: The same entities? Curr Opin Rheumatol 2003; 15: 587-590.
14. Schneider EM, Lorenz I, Muller-Rosenberger M, et al. Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Blood 2002; 100: 2891-2898.
15. McClain KL, Natkunam Y, Swerdlow SH. Atypical cellular disorders. Hematology (Am Soc Hematol Educ Program) 2004; 283-296.
16. Randolph GJ. Is maturation required for Langerhans cell migration? J Exp Med 2002; 196: 413-416.
17. Geissmann F, Lepelletier Y, Fraitag S, et al. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood 2001; 97: 1241-1248.
18. Egeler RM, Favara BE, Laman JD, et al. Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans cell histiocytosis lesions. Eur J Cancer 2000; 36: 2105-2110.
19. Fleming MD, Pinkus JL, Fournier MV, et al. Coincident expression of the chemokine receptors CCR6 and CCR7 by pathologic Langerhans cells in Langerhans cell histiocytosis. Blood 2003; 101: 2473-2475.
20. Geissmann F, Emile JF, Andry P, et al. Lack of expression of E-cadherin is associated with dissemination of Langerhans' cell histiocytosis and poor outcome. J Pathol 1997; 181: 301-304.
21. Rolland A, Guyon L, Gill M, et al. Increased blood myeloid dendritic cells and dendritic cell-poietins in Langerhans cell histiocytosis. J Immunol 2005; 174: 3067-3071.
22. Egeler RM, Neglia JP, Arico M, et al. The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society. Hematol Oncol Clin North Am 1998; 12: 369-378.
23. Egeler RM, Neglia JP, Puccetti DM, et al. Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer 1993; 71: 865- 873.
24. Egeler RM, Neglia JP, Arico M, et al. Acute leukemia in association with Langerhans cell histiocytosis. Med Pediatr Oncol 1994; 23: 81-85.
25. Willman CL, Busque L, Griffith BB, et al. Langerhans'-cell histiocytosis (histiocytosis X) - a clonal proliferative disease. N Engl J Med 1994; 331: 154-160.
26. Yu RC, Chu C, Buluwela L, et al. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet 1994; 343: 767-768.
27. Betts DR, Leibundgut KE, Feldges A, et al. Cytogenetic abnormalities in Langerhans cell histiocytosis. Br J Cancer 1998; 77: 552-555.
28. Murakami I, Gogusev J, Fournet JC, et al. Detection of molecular cytogenetic aberrations in Langerhans cell histiocytosis of bone. Hum Pathol 2002; 33: 555-560.
29. Nezelof C, Basset F. An hypothesis of Langerhans cell histiocytosis: The failure of the immune system to switch from an innate to an adaptive mode. Pediatr Blood Cancer 2004; 42: 398-400.
30. Yousem SA, Colby TV, Chen YY, et al. Pulmonary Langerhans' cell histiocytosis: Molecular analysis of clonality. Am J Surg Pathol 2001; 25: 630- 636.
31. Tazi A, Moreau J, Bergeron A, et al. Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: Importance of the cytokine microenvironment. J Immunol 1999; 163: 3511-3515.
32. Laman JD, Leenen PJ, Annels NE, et al. Langerhans-cell histiocytosis "insight into DC biology". Trends Immunol 2003; 24: 190-196.
33. Servet-Delprat C, Arnaud S, Jurdic P, et al. Flt3+ macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia. BMC Immunol 2002; 3: 15.
34. da Costa CE, Annels NE, Faaij CM, et al. Presence of osteoclast-like multinucleated giant cells in the bone and monostotic lesions of Langerhans cell histiocytosis. J Exp Med 2005; 201: 687-693.
35. Lavabre-Bertrand T, Bourquard P, Chiesa J, et al. Diabetes insipidus revealing acute myelogenous leukaemia with a high platelet count, monosomy 7 and abnormalities of chromosome 3: A new entity? Eur J Haematol 2001; 66: 66-69.
36. Breccia M, Petti MC, Ottaviani E, et al. Diabetes insipidus as first manifestation of acute myeloid leukaemia with EVI-1-positive, 3q21q26 syndrome and T cell-line antigen expression: What is the EVI-1 gene role? Br J Haematol 2002; 118: 438-441.
37. Prosch H, Grois N, Prayer D, et al. Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis. Pediatr Blood Cancer 2004; 43: 594-599.
38. Gadner H, Grois N, Arico, et al. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr 2001; 138: 728-734.
39. Titgemeyer C, Grois N, Minkov M, et al. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study. Med Pediatr Oncol 2001; 37: 108-114.
40. Haupt R, Nanduri V, Calevo MG, et al. Permanent consequences in Langerhans cell histiocytosis patients: A pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr Blood Cancer 2004; 42: 438-444.
41. Donadieu J, Rolon MA, Thomas C, et al. Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: A population-based study. J Pediatr 2004; 144: 344-350.
42. Grois N, Prayer D, Prosch H, et al. Neuropathology of CNS disease in Langerhans cell histiocytosis. Brain 2005; 128: 829-838.
43. Arico M, Nichols K, Whitlock JA, et al. Familial clustering of Langerhans cell histiocytosis. Br J Haematol 1999; 107: 883-888.
44. Fadeel B, Henter JI. Langerhans-cell histiocytosis: Neoplasia or unbridled inflammation? Trends Immunol 2003; 24: 409-410; author reply 410-411.